A new trading day began on Monday, with Guardant Health Inc (NASDAQ: GH) stock price up 9.46% from the previous day of trading, before settling in for the closing price of $16.07. GH’s price has ranged from $15.81 to $41.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 49.27%. Meanwhile, its annual earnings per share averaged 23.51%. With a float of $115.88 million, this company’s outstanding shares have now reached $121.63 million.
The extent of productivity of a business whose workforce counts for 1779 workers is very important to gauge.
Guardant Health Inc (GH) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.79%, while institutional ownership is 93.96%. The most recent insider transaction that took place on Mar 18 ’24, was worth 38,963. In this transaction Chief Information Officer of this company bought 2,187 shares at a rate of $17.82, taking the stock ownership to the 12,722 shares. Before that another transaction happened on Mar 04 ’24, when Company’s Director sold 100 for $19.05, making the entire transaction worth $1,905. This insider now owns 4,521 shares in total.
Guardant Health Inc (GH) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 23.51% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.80% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Here are Guardant Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.28, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -3.02 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
The latest stats from [Guardant Health Inc, GH] show that its last 5-days average volume of 1.81 million was inferior to 1.9 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 25.17%. Additionally, its Average True Range was 1.20.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 12.23%, which indicates a significant decrease from 30.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.46% in the past 14 days, which was higher than the 63.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.15, while its 200-day Moving Average is $26.79. Now, the first resistance to watch is $17.92. This is followed by the second major resistance level at $18.25. The third major resistance level sits at $18.83. If the price goes on to break the first support level at $17.02, it is likely to go to the next support level at $16.44. The third support level lies at $16.11 if the price breaches the second support level.
Guardant Health Inc (NASDAQ: GH) Key Stats
With a market capitalization of 2.14 billion, the company has a total of 121,713K Shares Outstanding. Currently, annual sales are 563,950 K while annual income is -479,450 K. The company’s previous quarter sales were 155,050 K while its latest quarter income was -187,040 K.
